Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Best week in 3 months for UK mid-caps as Aggreko jumps on buyout offer

Fri, 05th Feb 2021 09:21

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Aggreko tops mid-caps

* Insurer Beazley up after reassuring on 2021 profitability

* Retailer French Connection surges on takeover talks

* FTSE 100 down 0.2%, FTSE 250 adds 1.2%
(Updates to market close)

By Shivani Kumaresan

Feb 5 (Reuters) - British mid-caps rose on Friday, scoring
their best week since November, as power equipment supplier
Aggreko Plc soared following a buyout proposal and
faster vaccine rollouts supported hopes for a brisk economic
revival.

Aggreko surged 32.9% after saying it was in talks
over a possible 2.25 billion pound ($3.09 billion) buyout by
private equity groups TDR Capital LLP and I Squared Capital.

The mid-cap index rose 1.2% and the blue-chip FTSE
100 index fell 0.2%, with Unilever Plc and
AstraZeneca Plc the biggest drags on the latter.

Progress in vaccine distribution and expectations of a large
stimulus by U.S. President Joe Biden's administration helped
global markets trade near their record highs and led to the FTSE
100 gaining 1.3% this week.

"I think for UK the problem in vaccines is that even if we
are in the clear by May, we might still have essentially closed
borders, which will be a big weight to growth," said Neil
Wilson, chief market analyst at Markets.com.

"So Europe’s vaccine problems could become our problem too.
This has implications for equities."

AstraZeneca and Oxford University's COVID-19 vaccine
has similar efficacy against the British coronavirus variant as
it does to the previously circulating variants, the university
said.

The UK stock market has tracked a global rally following the
coronavirus-led crash last March, but lagged European and U.S.
peers on fears of a long road to pre-pandemic levels of economic
growth.

British house prices fell last month for the first time
since May as a boom in activity late last year started to lose
steam, mortgage lender Halifax said.

In company news, shares in Beazley jumped 14.9%
after the insurer said it was confident of returning to
profitability and bringing back its dividend during the course
of this year.

Shares of French Connection soared 66.1% after the
British fashion retailer said was is in takeover talks with two
possible suitors.
(Reporting by Shivani Kumaresan in Bengaluru. Editing by Amy
Caren Daniel and Mark Potter)

More News
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.